| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
PRIM Stock Overview
PT Royal Prima Tbk provides hospital services in Indonesia.
Royal Prima Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | Rp302.00 |
| 52 Week High | Rp625.00 |
| 52 Week Low | Rp180.00 |
| Beta | 0.031 |
| 1 Month Change | -4.43% |
| 3 Month Change | -19.25% |
| 1 Year Change | 65.03% |
| 3 Year Change | -32.89% |
| 5 Year Change | n/a |
| Change since IPO | -59.73% |
Recent News & Updates
Shareholder Returns
| PRIM | ID Healthcare | ID Market | |
|---|---|---|---|
| 7D | 11.0% | 3.4% | -1.0% |
| 1Y | 65.0% | 16.8% | 18.2% |
Return vs Industry: PRIM exceeded the ID Healthcare industry which returned 14.4% over the past year.
Return vs Market: PRIM exceeded the ID Market which returned 15.6% over the past year.
Price Volatility
| PRIM volatility | |
|---|---|
| PRIM Average Weekly Movement | 5.8% |
| Healthcare Industry Average Movement | 5.5% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in ID Market | 12.2% |
| 10% least volatile stocks in ID Market | 3.0% |
Stable Share Price: PRIM is not significantly more volatile than the rest of ID stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: PRIM's weekly volatility has decreased from 13% to 6% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | 823 | Tommy Leonard | https://www.royalprima.com |
PT Royal Prima Tbk provides hospital services in Indonesia. The company was founded in 2013 and is headquartered in Jakarta, Indonesia.
Royal Prima Fundamentals Summary
| PRIM fundamental statistics | |
|---|---|
| Market Cap | Rp895.43b |
| Earnings (TTM) | Rp125.91b |
| Revenue (TTM) | Rp619.09b |
8.1x
P/E Ratio1.7x
P/S RatioIs PRIM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PRIM income statement (TTM) | |
|---|---|
| Revenue | Rp619.09b |
| Cost of Revenue | Rp405.06b |
| Gross Profit | Rp214.03b |
| Other Expenses | Rp88.12b |
| Earnings | Rp125.91b |
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | 37.12 |
| Gross Margin | 34.57% |
| Net Profit Margin | 20.34% |
| Debt/Equity Ratio | 0% |
How did PRIM perform over the long term?
See historical performance and comparisonValuation
Is Royal Prima undervalued compared to its fair value and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PEG Ratio
PB vs Industry
8.14x
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate PRIM's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate PRIM's fair value for valuation analysis.
Price To Earnings Ratio
PE vs Industry: PRIM is good value based on its PE Ratio (8.1x) compared to the ID Healthcare industry average (20.2x).
PE vs Market: PRIM is good value based on its PE Ratio (8.1x) compared to the ID market (18.8x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate PRIM's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: PRIM is good value based on its PB Ratio (1x) compared to the ID Healthcare industry average (1.9x).
Future Growth
How is Royal Prima forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Future Growth Score
0/6Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE
16.7%
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Royal Prima has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Past Performance
How has Royal Prima performed over the past 5 years?
Past Performance Score
5/6Past Performance Score 5/6
Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE
57.5%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: PRIM has high quality earnings.
Growing Profit Margin: PRIM's current net profit margins (20.3%) are higher than last year (8.8%).
Past Earnings Growth Analysis
Earnings Trend: PRIM's earnings have grown significantly by 57.5% per year over the past 5 years.
Accelerating Growth: PRIM's earnings growth over the past year (594.3%) exceeds its 5-year average (57.5% per year).
Earnings vs Industry: PRIM earnings growth over the past year (594.3%) exceeded the Healthcare industry 121.6%.
Return on Equity
High ROE: PRIM's Return on Equity (12.7%) is considered low.
Financial Health
How is Royal Prima's financial position?
Financial Health Score
6/6Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Debt Coverage
Interest Coverage
Financial Position Analysis
Short Term Liabilities: PRIM's short term assets (IDR455.2B) exceed its short term liabilities (IDR167.1B).
Long Term Liabilities: PRIM's short term assets (IDR455.2B) exceed its long term liabilities (IDR8.3B).
Debt to Equity History and Analysis
Debt Level: PRIM is debt free.
Reducing Debt: PRIM has no debt compared to 5 years ago when its debt to equity ratio was 10.1%.
Debt Coverage: PRIM has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: PRIM has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Dividend
What is Royal Prima current dividend yield, its reliability and sustainability?
Dividend Score
0/6Dividend Score 0/6
Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Future Dividend Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate PRIM's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate PRIM's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if PRIM's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if PRIM's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as PRIM has not reported any payouts.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
7.3yrs
Average board tenure
CEO
Tommy Leonard (35 yo)
no data
Tenure
Dr. Tommy Leonard has been the President Director of PT Royal Prima Tbk since 2015. Dr. Leonard holds Bachelor’s Degree in Law, Dharmawangsa University (2008) Magister in Notary and Doctor of Law North Sum...
Board Members
Experienced Board: PRIM's board of directors are considered experienced (7.3 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
PT Royal Prima Tbk's employee growth, exchange listings and data sources
Key Information
- Name: PT Royal Prima Tbk
- Ticker: PRIM
- Exchange: IDX
- Founded: 2013
- Industry: Health Care Facilities
- Sector: Healthcare
- Implied Market Cap: Rp895.430b
- Shares outstanding: 3.39b
- Website: https://www.royalprima.com
Number of Employees
Location
- PT Royal Prima Tbk
- Jalan Letjen S Parman
- Kav. 22 - 24
- Jakarta
- Jakarta Raya
- Indonesia
Listings
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2022/05/18 00:00 |
| End of Day Share Price | 2022/05/18 00:00 |
| Earnings | 2021/09/30 |
| Annual Earnings | 2020/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.